A major contributor to this article appears to have a close connection with its subject.(December 2015) |
Richard Alan North FRS (born 20 May 1944) is a British biomedical scientist, and Professor Emeritus at the University of Manchester. North grew up in Halifax, West Yorkshire and attended Heath Grammar School, before studying at University of Aberdeen. He graduated in medicine (MB ChB) and in physiology (BSc). He took a PhD in the group of Hans Walter Kosterlitz, and worked in Aberdeen hospitals as house office and registrar.[ citation needed ]
North's research has been at the interface of physiology, pharmacology and neuroscience. As a PhD student, he discovered the two main classes of neuron in the enteric nervous system [1] and described new type of slow synaptic connection. [2] As a professor at Loyola University Stritch School of Medicine (1975–1981), the Massachusetts Institute of Technology(1981–1986), and the Vollum Institute, Oregon Heath Sciences University (1987–1993), he showed that opiates, as well as several other amine and peptide neurotransmitters, inhibit the activity of neurons by opening potassium-selective ion channels in the cell membrane. [3] [4] This required the development of a method to record electrical activity from single neurons maintained alive in thin brain slices. [5] With John Adelman, he cloned calcium- and voltage-gated potassium channels from the brain. [6] [7] At the Glaxo Institute for Molecular Biology (later Geneva Biomedical Research Institute, 1993–1998) he led the group that isolated complementary DNAs for the family of P2X receptors: these are membrane proteins and ion channels through which extracellular adenosine 5'-triphosphate (ATP) exerts many of its actions. [8]
North was Professor of Molecular Physiology at the University of Sheffield (1998–2004).
This section of a biography of a living person does not include any references or sources .(December 2015) |
From 2004 to 2011, he was Vice-President of the University of Manchester, serving both as Dean of its Faculty of Life Sciences (2004–2008) and Dean of its Faculty of Medical and Human Sciences (2006–2011), as well as being the inaugural Director of the Manchester Academic Health Sciences Centre. He served on the UK Medical Research Council (2001 to 2006), and was a member of the International Advisory Board of the Korea Research Council for Fundamental Science and Technology(2009–2011). From 2003-2006 he was President of the Physiological Society.
Alan North is also a mountaineer, and has climbed extensively throughout Scotland and the Alps. He has made several first ascents or new routes on peaks of Upernivik Island, Greenland, [9] [10] and other mountains in the Hindu Kush [11] of Afghanistan, and Peak Lenin in the Soviet Pamirs. [12] He is a long-standing member of the Scottish Mountaineering Club.
A neuron, neurone, or nerve cell is an excitable cell that fires electric signals called action potentials across a neural network in the nervous system. Neurons communicate with other cells via synapses, which are specialized connections that commonly use minute amounts of chemical neurotransmitters to pass the electric signal from the presynaptic neuron to the target cell through the synaptic gap.
The myenteric plexus provides motor innervation to both layers of the muscular layer of the gut, having both parasympathetic and sympathetic input, whereas the submucous plexus provides secretomotor innervation to the mucosa nearest the lumen of the gut.
Enflurane is a halogenated ether. Developed by Ross Terrell in 1963, it was first used clinically in 1966. It was increasingly used for inhalational anesthesia during the 1970s and 1980s but is no longer in common use.
The glycine receptor is the receptor of the amino acid neurotransmitter glycine. GlyR is an ionotropic receptor that produces its effects through chloride currents. It is one of the most widely distributed inhibitory receptors in the central nervous system and has important roles in a variety of physiological processes, especially in mediating inhibitory neurotransmission in the spinal cord and brainstem.
Molecular neuroscience is a branch of neuroscience that observes concepts in molecular biology applied to the nervous systems of animals. The scope of this subject covers topics such as molecular neuroanatomy, mechanisms of molecular signaling in the nervous system, the effects of genetics and epigenetics on neuronal development, and the molecular basis for neuroplasticity and neurodegenerative diseases. As with molecular biology, molecular neuroscience is a relatively new field that is considerably dynamic.
Purinergic receptors, also known as purinoceptors, are a family of plasma membrane molecules that are found in almost all mammalian tissues. Within the field of purinergic signalling, these receptors have been implicated in learning and memory, locomotor and feeding behavior, and sleep. More specifically, they are involved in several cellular functions, including proliferation and migration of neural stem cells, vascular reactivity, apoptosis and cytokine secretion. These functions have not been well characterized and the effect of the extracellular microenvironment on their function is also poorly understood.
The P2X receptors, also ATP-gated P2X receptor cation channel family, is a protein family that consists of cation-permeable ligand-gated ion channels that open in response to the binding of extracellular adenosine 5'-triphosphate (ATP). They belong to a larger family of receptors known as the ENaC/P2X superfamily. ENaC and P2X receptors have similar 3-D structures and are homologous. P2X receptors are present in a diverse array of organisms including humans, mouse, rat, rabbit, chicken, zebrafish, bullfrog, fluke, and amoeba.
SK channels are a subfamily of calcium-activated potassium channels. They are so called because of their small single channel conductance in the order of 10 pS. SK channels are a type of ion channel allowing potassium cations to cross the cell membrane and are activated (opened) by an increase in the concentration of intracellular calcium through N-type calcium channels. Their activation limits the firing frequency of action potentials and is important for regulating afterhyperpolarization in the neurons of the central nervous system as well as many other types of electrically excitable cells. This is accomplished through the hyperpolarizing leak of positively charged potassium ions along their concentration gradient into the extracellular space. This hyperpolarization causes the membrane potential to become more negative. SK channels are thought to be involved in synaptic plasticity and therefore play important roles in learning and memory.
P2X purinoceptor 1, also ATP receptor, is a protein that in humans is encoded by the P2RX1 gene.
Potassium channel subfamily K member 2, also known as TREK-1, is a protein that in humans is encoded by the KCNK2 gene.
Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, also known as KCNN2, is a protein which in humans is encoded by the KCNN2 gene. KCNN2 is an ion channel protein also known as KCa2.2.
Hyperpolarization-activated cyclic nucleotide–gated (HCN) channels are integral membrane proteins that serve as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. HCN channels are sometimes referred to as pacemaker channels because they help to generate rhythmic activity within groups of heart and brain cells. HCN channels are activated by membrane hyperpolarization, are permeable to Na + and K +, and are constitutively open at voltages near the resting membrane potential. HCN channels are encoded by four genes and are widely expressed throughout the heart and the central nervous system.
P2X purinoceptor 2 is a protein that in humans is encoded by the P2RX2 gene.
P2X purinoceptor 3 is a protein that in humans is encoded by the P2RX3 gene.
A channel blocker is the biological mechanism in which a particular molecule is used to prevent the opening of ion channels in order to produce a physiological response in a cell. Channel blocking is conducted by different types of molecules, such as cations, anions, amino acids, and other chemicals. These blockers act as ion channel antagonists, preventing the response that is normally provided by the opening of the channel.
Stephen J Smith is Meritorious Investigator at the Allen Institute for Brain Science [1] and Emeritus Professor of Molecular and Cellular Physiology at Stanford University [2]. He held faculty and Howard Hughes Medical Institute positions at the Yale University School of Medicine 1980-1989. He served 1990-2014 as a Stanford Professor, teaching many courses in synaptic physiology and cellular microscopy while mentoring many students and fellows [3]. He also taught in many expert workshops and summer courses at the Woods Hole Marine Biological Laboratory and the Cold Spring Harbor Laboratory.
Colin G. Nichols FRS is the Carl Cori Endowed Professor, and Director of the Center for Investigation of Membrane Excitability Diseases at Washington University in St. Louis, Missouri.
Graeme Henderson is a British neuroscientist whose research focuses on opioid addiction. He is professor of pharmacology in the School of Physiology, Pharmacology and Neuroscience, University of Bristol.
Raymond J Dingledine is an American pharmacologist and neurobiologist who has made considerable contributions to the field of epilepsy. He serves as Professor in the School of Medicine at Emory University, Atlanta GA, where he chaired the pharmacology department for 25 years and served as Executive Associate Dean of Research for 10 years.
Alexander G. Obukhov is an American researcher, who specializes in ion channels, molecular physiology, and vascular biology. Since 1986, Obukhov published research articles, with the most notable ones published in academic journals such as Nature, Journal of Biological Chemistry, EMBO Journal, Journal of Cell Biology, Proceedings of the National Academy of Sciences of the United States of America, and Neuron. Obukhov's research later evolved to feature multiple fields including neurophysiology, traumatic brain injury, pain, and atherosclerosis.